LIVE ESMO GI 2026 Live — top KOL voices, trial buzz & conference slides from Munich View Live Coverage →
KOL Pulse Insights Blog

Oncology KOL Intelligence, decoded.

Key opinion leader trends, clinical-trial commentary, conference recaps, and AI-native intelligence on the physicians shaping oncology practice — straight from the social conversation.

1Articles
WeeklyNew insights
500+Verified oncologists tracked
0 articles · All topics
Is Ivonescimab Too Good To Be True? Highlights of Dr. John Heymach's Uromigos Podcast
Mar 26, 2025 5:34:39 PM Brian Shields

Is Ivonescimab Too Good To Be True? Highlights of Dr. John Heymach's Uromigos Podcast

Dr. John Heymach provided the Uromigos with a review on the HARMONi-2 trial of ivonescimab in NSCLC

lung cancerivonescimaburomigos

Track the KOLs shaping oncology

KOL Pulse turns the oncology social conversation into AI-native intelligence. See it in action.

Book a Demo Back to Homepage